Raxibacumab
From Self-sufficiency
Revision as of 17:53, 14 July 2010 by Citation bot 1 (Talk) (Citations: [Pu173] added: first2, first3, first4, first5, first6, first7, first8, first9. You can use this bot yourself! Report bugs here.)
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Template:Infobox drug/mab source |
| Target | Protective antigen of anthrax toxin |
| Identifiers | |
| CAS Number | 565451-13-0 |
| ATC code | none |
| Chemical data | |
| Formula | C6320H9794N1702O1998S42 |
| Molar mass | 142.93 kDa[[Script error: No such module "String".]] |
Raxibacumab is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax. Its efficacy has been proved in rabbits and monkeys.[1] As of September 2009[update], its safety in humans is being evaluated.[2]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 40x30px | This monoclonal antibody-related article is a stub. You can help ssf by expanding it. |
- ↑ Migone, TS; Subramanian, GM; Zhong, J; Healey, LM; Corey, A; Devalaraja, M; Lo, L; Ullrich, S; Zimmerman, J (2009). "Raxibacumab for the treatment of inhalational anthrax". The New England journal of medicine. 361 (2): 135–44. doi:10.1056/NEJMoa0810603. PMID 19587338.
- ↑ ClinicalTrials.gov
Categories:
- Pages with script errors
- Drugs that are a monoclonal antibody
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Articles containing potentially dated statements from September 2009
- Articles with invalid date parameter in template
- All articles containing potentially dated statements
- 2Fix
- Pages with broken file links
- Monoclonal antibody stubs
